Immuneering Corp Sustainability Reports
Immuneering Corporation is a clinical-stage oncology company that develops medicines for broad populations of cancer patients. The company leverages its proprietary computational biology platform and deep biological insights to discover and advance a pipeline of targeted cancer therapies.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG009QXJQV7
6 reports from 2021 to 2025
